Last Posted: Nov 29, 2018
- A Pharmacogenomic-based Antidepressant Treatment for Patients with Major Depressive Disorder: Results from an 8-week, Randomized, Single-blinded Clinical Trial.
Han Changsu et al. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology 2018 Nov 16(4) 469-480 - Statistical pitfalls of personalized medicine
S Senn, Nature News, November 27, 2018 - Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multi-center COGENT Study.
Beri Nina et al. Clinical genetics 2018 Nov - Genetics of response to cognitive behavior therapy in adults with major depression: a preliminary report.
Andersson Evelyn et al. Molecular psychiatry 2018 Nov - Pharmacogenetic guidelines and decision support tools for depression treatment: application to late-life.
Chang Donald D et al. Pharmacogenomics 2018 Nov 19(16) 1269-1284 - Using genetics to understand the causal influence of higher BMI on depression.
Tyrrell Jessica et al. International journal of epidemiology 2018 Nov - Cost-Effectiveness of a Pharmacogenetic Test to Guide Treatment for Major Depressive Disorder.
Groessl Erik J et al. Journal of managed care & specialty pharmacy 2018 Aug 24(8) 726-734 - Impacts for Children Living with Genetic Muscle Disorders and their Parents - Findings from a Population-Based Study.
Jones Kelly M et al. Journal of neuromuscular diseases 5(3) 341-352 - Clinical implications of APOE genotyping for late-onset Alzheimer's disease (LOAD) risk estimation: a review of the literature.
Marshe Victoria S et al. Journal of neural transmission (Vienna, Austria : 1996) 2018 Oct - Novel genome-wide associations for suicidality in UK Biobank, genetic correlation with psychiatric disorders and polygenic association with completed suicide.
RJ Strawbridge et al, BIORXIV, October 25, 2018
.png)
No hay comentarios:
Publicar un comentario